<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-BOC-17011649</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-06-13</date_registration>
      <primary_sponsor>Department of Dermatology, Affiliated Hospital of Jiangsu University</primary_sponsor>
      <public_title>Individualized induced pluripotent stem cells from the fibroblasts of patients’ lesions with different skin diseases</public_title>
      <acronym />
      <scientific_title>Individualized induced pluripotent stem cells from the fibroblasts of patients’ lesions with different skin diseases</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-06-20</date_enrolment>
      <type_enrolment />
      <target_size>Healthy group:3;vitiligo group:3;Keloid group:3;skin malignant tumor:3;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=19856</url>
      <study_type>Basic science</study_type>
      <study_design>Cohort study</study_design>
      <phase>Other</phase>
      <hc_freetext> keloid, psoriasis, skin malignant tumo</hc_freetext>
      <i_freetext>Healthy group:Take the skin;vitiligo group:Take the skin;Keloid group:Take the skin;skin malignant tumor:Take the skin;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Zhang Yixuan</firstname>
        <middlename />
        <lastname />
        <address>438 Jiefang Road, Zhenjiang, Jiangsu, China</address>
        <city />
        <country1 />
        <zip>212000</zip>
        <telephone>+86 18796017250</telephone>
        <email>tenwenhua@126.com</email>
        <affiliation>Jiangsu University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>LI Yumei</firstname>
        <middlename />
        <lastname />
        <address>438 Jiefang Road, Zhenjiang, Jiangsu, China</address>
        <city />
        <country1 />
        <zip>212000</zip>
        <telephone>+86 13914569541</telephone>
        <email>l.yumei@aliyun.com</email>
        <affiliation>Jiangsu University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>suffering from keloids, vitiligo, psoriasis, skin cancer patients need surgery
          </inclusion_criteria>
      <agemin>15</agemin>
      <agemax>80</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Obvious signs and signs of infection, or laboratory tests without evidence of infection
2. Immunosuppressive drugs such as systemic immune function were used in the month before treatment
3. Dermatitis, psoriasis, rheumatoid arthritis and other autoimmune diseases and other allergic diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Age;Disease type;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National Natural Science Foundation of China (81573053); The '333' Project of Jiangsu Province (BRA2015196); The Science and Technology Project in Zhenjiang (No.SS2015024)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-12-12</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>